Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Academy for Sickle Cell and Thalassaemia (ASCAT 2026) 7 - 10 October 2026

Etavopivat reduces transfusion in adults and adolescents with transfusion-dependent α- or β-thalassaemia: Phase 2 results

Authors :

Ashutosh Lal^1*, Saranya Veluswamy², Melanie Kirby-Allen³, Yves Dominique Pastore⁴, Janet L. Kwiatkowski⁵, E. Leila Jerome Clay⁶, Olga Polyanskaya⁷, Navid Nedjatian⁸, Ali T. Taher⁹

Affiliations

View Details Hide Details

Keywords

Thalassemia

Congress oral presentation

Etavopivat